ArticleEuropean journal of medical research2026
Demographic and geographic hotspots of Alzheimer's disease and pneumonia-related mortality among older adults in the United States: a retrospective analysis.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The changing epidemiology of infection-associated mortality in Alzheimer's disease in the United States, 1999-2024.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlder patients with Alzheimer's disease (AD) are more susceptible to pneumonia because of their limited mobility, malnourishment, and difficulty swallowing. This study highlights demographic and geographic while examining AD and pneumonia-related mortality rates among older adults in the United States (U.S.) between 1999 and 2023.
methodsRetrospective cohort research utilized mortality data from the Centre for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC-WONDER). Demographic factors (age, gender, race/ethnicity) and geographic classifications (urbanization, regions, states) were examined during the analysis. We used joinpoint regression and standardization techniques to determine age-adjusted mortality rates (AAMR) and annual percentage changes (APC).
resultsA total of 202,678 AD and pneumonia-related deaths were reported. Overall AAMR declined significantly from 1999 to 2023 (APC - 6.65; P < 0.05). From demographics males (22), non-Hispanic (NH) Whites (20.8), individuals aged 85 + years (98.3) had the highest mortality rates. Geographically, residents of non-metropolitan (25.6) and west regions (26.9) represented peak rates.
conclusionWe observed notable demographic and geographic disparities in AD and pneumonia associated mortality, the burden of which is higher among males, NH Whites and those residing in non-metropolitan regions and therefore we emphasize the need of targeted interventions and equitable resource allocation to reduce this burden especially among high-risk populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.